Gyre Therapeutics, Inc. GYRE Gyre — Interest Income Expense Net
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.
The official record: Gyre Therapeutics, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gyre — interest income expense net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s gyre — interest income expense net?
- Gyre Therapeutics, Inc. (GYRE) reported gyre — interest income expense net of $155.25K in Q4 2025.
- How has Gyre Therapeutics, Inc.'s gyre — interest income expense net changed year-over-year?
- Gyre Therapeutics, Inc.'s gyre — interest income expense net increased by 167.7% year-over-year, from $58K to $155.25K.
- What does gyre — interest income expense net mean?
- This metric represents the net balance of interest income earned on cash and investments versus interest expense incurred on debt obligations specifically attributed to the segment. It highlights the segment's net financing cost or return on its internal capital structure. A positive value indicates the segment is a net generator of interest income, while a negative value indicates a net cost of capital.